A Randomized, Double-Blind Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2015
At a glance
- Drugs Denosumab (Primary)
- Indications Bone resorption; Postmenopausal osteoporosis
- Focus Registrational; Therapeutic Use
- Acronyms DEFEND
- 02 Feb 2011 Results published in the Journal of Clinical Endocrinology and Metabolism.
- 11 Sep 2009 Data from the extension phase of study have been reported at the 31st Annual Meeting of the American Society for Bone and Mineral Research.
- 12 May 2009 Actual end date (1 Aug 2004) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History